Creo Medical Group Future Growth
Future criteria checks 2/6
Creo Medical Group is forecast to grow earnings and revenue by 61.1% and 23.4% per annum respectively. EPS is expected to grow by 82.1% per annum. Return on equity is forecast to be -11.8% in 3 years.
Key information
61.1%
Earnings growth rate
82.1%
EPS growth rate
| Medical Equipment earnings growth | 21.4% |
| Revenue growth rate | 23.4% |
| Future return on equity | -11.8% |
| Analyst coverage | Low |
| Last updated | 04 Mar 2024 |
Recent future growth updates
Recent updates
Market Cool On Creo Medical Group PLC's (LON:CREO) Revenues Pushing Shares 26% Lower
Mar 02
Revenues Tell The Story For Creo Medical Group PLC (LON:CREO) As Its Stock Soars 29%
Dec 29Is Creo Medical Group (LON:CREO) Weighed On By Its Debt Load?
Oct 06Creo Medical (LON:CREO) Is In A Good Position To Deliver On Growth Plans
Feb 03
How Many Creo Medical Limited (LON:CREO) Shares Do Institutions Own?
Dec 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 54 | -2 | 1 | N/A | 1 |
| 12/31/2024 | 41 | -11 | -9 | -16 | 3 |
| 12/31/2023 | 32 | -18 | -14 | -19 | 3 |
| 6/30/2023 | 29 | -25 | -25 | -24 | N/A |
| 3/31/2023 | 28 | -26 | -27 | -24 | N/A |
| 12/31/2022 | 27 | -27 | -28 | -25 | N/A |
| 9/30/2022 | 26 | -28 | -33 | -28 | N/A |
| 6/30/2022 | 26 | -28 | -38 | -30 | N/A |
| 3/31/2022 | 26 | -26 | -35 | -28 | N/A |
| 12/31/2021 | 25 | -25 | -32 | -26 | N/A |
| 9/30/2021 | 24 | -23 | -26 | -22 | N/A |
| 6/30/2021 | 22 | -21 | -19 | -19 | N/A |
| 3/31/2021 | 16 | -21 | -18 | -18 | N/A |
| 12/31/2020 | 9 | -20 | -17 | -16 | N/A |
| 9/30/2020 | 5 | -19 | -17 | -16 | N/A |
| 6/30/2020 | 0 | -17 | -17 | -16 | N/A |
| 3/31/2020 | 0 | -17 | -15 | -14 | N/A |
| 12/31/2019 | 0 | -16 | -13 | -12 | N/A |
| 6/30/2019 | 0 | -13 | -14 | -13 | N/A |
| 3/31/2019 | 0 | -12 | -12 | -11 | N/A |
| 12/31/2018 | N/A | -10 | -10 | -10 | N/A |
| 12/31/2017 | 0 | -8 | -10 | -9 | N/A |
| 9/30/2017 | 0 | -8 | -9 | -8 | N/A |
| 6/30/2017 | N/A | -8 | -7 | -7 | N/A |
| 6/30/2016 | 1 | -5 | N/A | -5 | N/A |
| 2/29/2016 | 1 | -3 | N/A | -3 | N/A |
| 2/28/2015 | N/A | -2 | N/A | -2 | N/A |
| 2/28/2014 | 1 | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CREO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CREO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CREO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CREO's revenue (23.4% per year) is forecast to grow faster than the UK market (3.3% per year).
High Growth Revenue: CREO's revenue (23.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CREO is forecast to be unprofitable in 3 years.